Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Photoactivatable platinum complexes.

Patrick J Bednarski1, Fiona S Mackay, Peter J Sadler

  • 1Department of Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, University of Greifswald, 17487 Greifswald, Germany. bednarsk@uni-greifswald.de

Anti-Cancer Agents in Medicinal Chemistry
|February 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genomic mapping reveals cisplatin disruption of protein phosphorylation signalling genome-wide.

Metallomics : integrated biometal science·2026
Same author

In Vivo Imaging of a Photoactivatable Platinum Prodrug by Metal-Centered Radiolabeling.

Journal of the American Chemical Society·2026
Same author

A Correlative X‑ray Bioimaging Triad for Metals in Biomedical Research.

Chemical & biomedical imaging·2026
Same author

In Situ Lipid Interactions of an Anticancer Metal Complex.

Inorganic chemistry·2026
Same author

Bioassay-guided isolation and identification of antiproliferative compounds from Acokanthera schimperi (A.DC.) Schweinf and Gnidia involucrata Steudel ex A. Rich.

Fitoterapia·2026
Same author

Multichiral Half-Sandwich Ru(II) and Os(II) Anticancer Complexes Containing a Glutathione Synthesis Inhibitor.

Organometallics·2025
Same journal

Emerging Frontiers in Nanomedicine for Colorectal Cancer: A Review of Therapeutic Advances, Clinical Evidence, and Patented Technologies.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Microfluidic Synthesis of miR-10a Antisense Oligonucleotides-Loaded LNP Combined with Cisplatin for Colorectal Cancer Therapy.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Synergistic Anticancer Effect of Luteolin and Etoposide via the PI3K/AKT Signaling Pathway.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Targeting Eg5 with K858: A Strategy for Radiosensitization Through ROS-Mediated DNA Damage in Esophageal Squamous Cell Carcinoma.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Pulsatilla chinensis Saponins as Multitargeted Anticancer Agents: A Mini-Review of Molecular Mechanisms and Therapeutic Potential.

Anti-cancer agents in medicinal chemistry·2026
Same journal

Efficacy and Safety of Pembrolizumab as Monotherapy and in Combination with Chemotherapy versus Chemotherapy Alone for Advanced Gastric or Gastroesophageal Junction Cancer: A Systematic Review and Meta-Analysis.

Anti-cancer agents in medicinal chemistry·2026
See all related articles

Photoactivatable platinum(IV) complexes offer targeted cancer therapy. Diazido-Pt(IV) compounds are stable in the dark but become potent antitumor agents under light, showing promise for selective cancer treatment.

Area of Science:

  • Medicinal Chemistry
  • Photochemistry
  • Cancer Therapeutics

Background:

  • Platinum-based drugs are crucial in cancer treatment but suffer from toxicity and lack of selectivity.
  • Photoactivatable prodrugs aim to enhance selectivity and reduce toxicity by light-triggered activation.
  • Platinum(IV) complexes are suitable candidates due to their inertness, requiring reduction to cytotoxic Platinum(II) species.

Purpose of the Study:

  • To design, synthesize, and evaluate photoactivatable platinum(IV) prodrugs for cancer therapy.
  • To investigate the photochemistry and biological activity of diiodo- and diazido-platinum(IV) complexes.
  • To assess the selectivity and toxicity profiles of these novel platinum-based agents.

Main Methods:

  • Synthesis of diiodo- and diazido-platinum(IV) diam(m)ine complexes, including analogs of cisplatin and transplatin.

Related Experiment Videos

  • Investigation of photochemistry, including DNA binding and adduct formation with 5'-GMP upon irradiation.
  • Evaluation of cytotoxicity against human cancer cells in vitro and stability against biological thiols like glutathione.

    • Main Results:

    • Diiodo-Pt(IV) complexes showed photoreactivity and cytotoxicity but were unstable towards glutathione.
    • Diazido-Pt(IV) complexes demonstrated light-activated DNA binding and cytotoxicity with excellent stability against glutathione.
    • The all-trans diazido-Pt(IV) analog was non-toxic in the dark but highly active as cisplatin under light, killing cancer cells effectively.

    Conclusions:

    • Photoactivatable platinum(IV) antitumor agents represent a promising strategy for targeted cancer therapy.
    • Diazido-Pt(IV) complexes offer improved stability and light-dependent activation, overcoming limitations of earlier generations.
    • These findings support the development of novel, selective platinum-based chemotherapeutics for localized tumor treatment.